Biggest News Aggregation in the World
๐Ÿ“ฐ With Phase News

Page 2 - With Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from With Phase. Real-time updates on events, politics, business and more.

Takeda Pharmaceutical Company Limited: Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3

Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase Inhibitor
United States Hong Kong Brendan Jennings Schwierige Zeiten Christopher Oreilly International Financial Reporting Standards

Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3

Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase... | February 2, 2023
United States Hong Kong International Financial Reporting Standards European Commission Arrowhead Pharmaceuticals Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Kazia Therapeutics Ltd and its flagship asset have made significant progress against brain cancers: Pitt Street Research

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has more good news to come out, including results from a Phase 3 trial against glioblastoma, data from several...
Research Emerging Stocks Down Global Coalition For Adaptive Research Simcere Pharmaceutical Group Kazia Therapeutics Ltd Pitt Street Research Emerging Stocks Down Under

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science